Three Lab Warnings in Five Days, Researcher Flags “Gambling with Our Lives,” and Labs Race
Peter Diamandis, Emad Mostaque, Alex Wissner-Gross, Dave Blundin and Salim Ismail debate a wave of AI safety warnings, OpenAI's claimed Navier-Stokes result, falling AI costs, chip scarcity and an AI-designed longevity drug.
The gist
-
Alex cites a Dwarkesh Patel and Jerry Han study finding better training data gave 12x efficiency gains versus 3.7x from better architectures.
-
After researcher Jacob Coxin quit citing reckless labs, Alex dismissed it as virtue signaling while Emad predicted AI risk would dominate Washington's agenda.
-
Noam Brown notes results costing $500,000 in the o3 era now cost $20, and the hosts urge PhD students to rethink their plans.
-
The hosts praise 3Blue1Brown as proof one creator can make documentary-quality explainers, saying AI tools now cut video costs 10 to 100 times.
-
Peter says Insilico's AI-designed drug reached phase three, and Alex calls its 3 to 4 years of aging-clock reversal in four weeks an escape-velocity spike.
Peter Diamandis recommends it
"Do you guys ever watch any of those 3Blue1Brown videos? They're absolutely brilliant, explaining complicated topics in physics and math and how a transformer works. The quality of the production is like documentary caliber awesomeness, but it's done by a single visionary creat..."
▶ Play at 1:24:21What they recommend · 2 picks
"If you haven't read that paper, it's an interesting future fiction of two different scenarios. It's worth going and reading."
"Do you guys ever watch any of those 3Blue1Brown videos? They're absolutely brilliant, explaining complicated topics in physics and math and how a transformer works. The quality ..."
Peter, Emad, Joe and John agree on 14 things
See what they all use, in their own words. Paid ads are left out.
See what they all swear by Or pick your own peopleMade by someone on this episode
Also mentioned
Ads in this episode
Fountain Life, Abundance Summit, Google for Startups, Blitzy. They're paid, so we keep them out of the picks above.
See what Peter recommends without being paid →Related episodes
Episodes covering similar topics
More from Peter Diamandis